Dr. Wei (William) CAO is the Founder, Chairman and CEO of Gracell Biotechnologies Group. Together with an industry veteran team, Dr. Cao has created Gracell to capture special opportunity of cell therapy for global market. Through external partnership and in-house R&D effort, Gracell has been rapidly progressing with novel CAR-T programs to address the industry’s key issues.
He is a seasoned front runner with over three decades of experience in biotech and R&D. Before conception of Gracell today, he was the co-founder and CEO of a Nasdaq listed cell therapy company; served as senior scientific management positions at Chiron (Novartis and Bayer) and Affymetrix (ThermoFisher). William also has over 70 issued patents and applications for advanced cell therapies.
Dr. Cao earned a Bachelor’s degree in Medicine from Fudan University / Shanghai Medical College, China and a PhD degree in Pharmacology from Medical College of Virginia, USA. He has extensive research experience in immune-pharmacology field at Harvard Medical School and Stanford University Medical Center. He is the director of International Chinese Stem Cell Foundation (ICSCF), and served as Venture Partner of 6 Dimensions Capital. Dr. Cao received prestigious White Magnolia Award from Shanghai City.